Pharma and Biotech
Fundraising and Proposed Capital Reorganisation | 30-Jan-2024 | 07:04 | RNS |
R&D Tax Credit | 30-Jan-2024 | 07:02 | RNS |
Half-year Report | 30-Jan-2024 | 07:00 | RNS |
Notice of Results | 23-Jan-2024 | 07:00 | RNS |
Patent Applications | 10-Jan-2024 | 07:00 | RNS |
Directorate Appointment | 14-Nov-2023 | 07:00 | RNS |
TR-1: Notification of major holdings | 24-Oct-2023 | 07:00 | RNS |
TR-1: Notification of major holdings | 20-Oct-2023 | 07:01 | RNS |
Director Dealing | 20-Oct-2023 | 07:00 | RNS |
Phase I Clinical Trial Results | 10-Oct-2023 | 07:00 | RNS |
Result of AGM | 29-Sep-2023 | 07:00 | RNS |
Final Dose Administered | 25-Sep-2023 | 07:00 | RNS |
Notice of AGM | 05-Sep-2023 | 16:18 | RNS |
2023 Final Results | 31-Aug-2023 | 07:00 | RNS |
Notice of Results | 22-Aug-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.37p |
Change Today | 0.005p |
% Change | -1.35 % |
52 Week High | 1.43 |
52 Week Low | 0.34 |
Volume | 4,212,761 |
Shares Issued | 1,088.42m |
Market Cap | £3.97m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:58 | 300,000 @ 0.37p |
14:50 | 500,000 @ 0.37p |
13:53 | 13,446 @ 0.37p |
13:53 | 1,355 @ 0.37p |
13:53 | 694 @ 0.36p |
CEO | Clarissa Ann Sowemimo- Coke |
You are here: research